Biophytis - New Therapeutics for aging diseases Employee Directory

Biotechnology ResearchÎle-de-france, France11-50 Employees

Biophytis SA is a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging.

Our small molecules are aimed at stimulating biological resilience to stress during aging.

Ruvembri - in regulatory and clinical phases - is our leading drug candidate is administered orally:

• for the treatment of severe respiratory events related to COVID-19 following positive results in Phase 2/3 clinical study (COVA)
• for the treatment of reduced mobility in elderly patients with sarcopenia, with promising results in a Phase 2 clinical study (SARA) conducted in the United States and Europe


A pediatric formulation of Ruvembri is being developed with IND granted in the US and Belgium (MYODA) for the treatment of Duchenne Muscular Dystrophy (DMD).

Find Biophytis - New Therapeutics for aging diseases employees' phone numbers or email addresses

Biophytis - New Therapeutics for aging diseases Global Highlights

Location
Employees

Europe
23

Minus sign iconPlus sign icon
  • France
    23

Asia
1

Minus sign iconPlus sign icon
  • Turkey
    1

North America
1

Minus sign iconPlus sign icon
  • United States Of America
    1

South America
1

Minus sign iconPlus sign icon
  • Brazil
    1

Biophytis - New Therapeutics for aging diseases's Leadership

  • Stylized image of a person
    C. B.
    Chief Pharmaceutical Officer & Qa Director
    Phone icon
  • Stylized image of a person
    P. J. D.
    Chief Scientific Officer, Ip Director
    Phone icon
  • Stylized image of a person
    W. D.
    Chief Clinical Officer
    Phone icon
  • Stylized image of a person
    S. V.
    President And Ceo
    Phone icon
  • Stylized image of a person
    C. S.
    Founder
    Phone icon
  • Stylized image of a person
    S. M.
    Senior Director, Head Of Regulatory Affairs
    Phone icon
  • Stylized image of a person
    C. F.
    Medical Director
    Phone icon
  • Stylized image of a person
    C. T.
    Program Director
    Phone icon

Biophytis - New Therapeutics for aging diseases Employee Metrics

100%
50%
0%
2026
2025
  • Biotechnology
  • Business
  • Entrepreneurship
  • Pharmaceuticals
  • Human Resources
  • Other
  • Consultant
  • Administrative

Contact profiles from Biophytis - New Therapeutics for aging diseases

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    C. B.
    Chief Pharmaceutical Officer & Qa Director
    Phone icon
    FranceÎle-de-France
    Apr 25, 2026
  • Stylized image of a person
    P. J. D.
    Chief Scientific Officer, Ip Director
    Phone icon
    FranceÎle-de-France
    Apr 29, 2026
  • Stylized image of a person
    S. V.
    President And Ceo
    Phone icon
    FranceÎle-de-France
    Apr 25, 2026
  • Stylized image of a person
    W. D.
    Chief Clinical Officer
    Phone icon
    FranceParis
    Apr 20, 2026
  • Stylized image of a person
    C. S.
    Founder
    Phone icon
    Oct 16, 2024
  • Stylized image of a person
    S. M.
    Senior Director, Head Of Regulatory Affairs
    Phone icon
    United StatesMassachusetts
    Apr 25, 2026
  • Stylized image of a person
    C. F.
    Medical Director
    Phone icon
    FranceÎle-de-France
    Apr 25, 2026
  • Stylized image of a person
    C. T.
    Program Director
    Phone icon
    FranceÎle-de-France
    Apr 25, 2026
  • Stylized image of a person
    S. R.
    Clinical Operation Lead
    Phone icon
    FranceÎle-de-France
    Apr 25, 2026
  • Stylized image of a person
    L. E. E.
    Clinical Operations Manager Latam
    Phone icon
    BrazilSão Paulo
    Apr 25, 2026

Frequently Asked Questions

What is Biophytis - New Therapeutics for aging diseases known for?

Minus sign iconPlus sign icon
Biophytis - New Therapeutics for aging diseases was founded in 2006 operates in the Biotechnology Research industry. The company's main headquarters is located in 4 Place Jussieu Paris Ile de France Paris, Île-de-france 75005 France; you can contact the main corporate office by phone at . Explore Biophytis - New Therapeutics for aging diseases's company overview page for more information.

What is Biophytis - New Therapeutics for aging diseases's most common email format?

Minus sign iconPlus sign icon
Biophytis - New Therapeutics for aging diseases employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Biophytis - New Therapeutics for aging diseases email formats with LeadIQ.

How many employees does Biophytis - New Therapeutics for aging diseases have currently?

Minus sign iconPlus sign icon
Biophytis - New Therapeutics for aging diseases has approximately 23 employees as of April 2026. These team members are located across 4 continents, including EuropeAsiaNorth America.

Who are Biophytis - New Therapeutics for aging diseases's key employees and leadership?

Minus sign iconPlus sign icon

As of April 2026, Biophytis - New Therapeutics for aging diseases's key employees include:

  • Chief Pharmaceutical Officer & Qa Director: C. B.
  • Chief Scientific Officer, Ip Director: P. J. D.
  • Chief Clinical Officer: W. D.
  • President And Ceo: S. V.
  • Founder: C. S.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.